LGT Capital Partners portfolio
Concentrated managerType not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 5, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
LGT Capital Partners reported a $2.0 bn portfolio of 38 positions to the SEC as of the end of Q2 2026. Its largest positions are NVDA, GOOGL, MSFT. During the quarter it opened Boston Scientific and Eli Lilly and exited ResMed.
Sections with a free account
What changed this quarter
37 positions with a change (3 new, 15 added to, 16 trimmed, 3 sold). 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Microsoft−31%fewer sharesReduced9.5% → 6.3%
- Alphabet−20%fewer sharesReduced9.1% → 8.6%
- Palo Alto Networks−61%fewer sharesReduced2.2% → 1.8%
- Boston Scientific+2.0 ppof portfolioNew— → 2.0%
- Eli Lilly+1.5 ppof portfolioNew— → 1.5%
- ResMed−1.2 ppof portfolioSold out1.3% → —
- Agilent Technologies−21%fewer sharesReduced5.1% → 4.5%
- ServiceNow+1.2 ppof portfolioNew— → 1.2%
- Broadcom+42%more sharesIncreased2.0% → 3.4%
- Netflix+52%more sharesIncreased2.5% → 2.7%
- Taiwan Semiconductor Manufacturing−13%fewer sharesReduced5.2% → 6.2%
- Apple+16%more sharesIncreased4.9% → 6.2%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- NVIDIANVDA10.0%
- AlphabetGOOGL8.6%
- MicrosoftMSFT6.3%
- AppleAAPL6.2%
- Taiwan Semiconductor ManufacturingTSM6.2%
- Agilent TechnologiesA4.5%
- MastercardMA4.0%
- AutoZoneAZO3.4%
- BroadcomAVGO3.4%
- Ross StoresROST3.0%
- NetflixNFLX2.7%
- StrykerSYK2.6%
- XylemXYL2.6%
- Colgate-palmoliveCL2.5%
- Church & DwightCHD2.5%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Information Technology 39%
- ● Health Care 16%
- ● Communication Services 11%
- ● Financials 11%
- ● Consumer Discretionary 8%
- ● Industrials 7%
- ● Consumer Staples 5%
- ● Utilities 2%
How its portfolio changed (8 quarters)
Q2 2026: 38
Q2 2026: 56%
Q2 2026: 12.4%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified. It meets the portfolio criteria of a concentrated manager, but its type is not verified: we found no official document that is enough to say what kind of entity it is. It may be an investment firm, but also an adviser adding up client accounts, a bank or a family vehicle. It counts in the tallies like the rest; keep that in mind when reading it. How the type is assigned
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Gobi CapitalInvestment firm · $2.0 bn
- Prescott General PartnersInvestment firm · $2.0 bn
- Casdin CapitalInvestment firm · $2.0 bn
- Cormorant Asset ManagementInvestment firm · $2.0 bn
- Voss CapitalInvestment firm · $2.0 bn
- Progeny 3$1.9 bn